Use of multicellular spheroids and agent-based modelling to optimise combination therapies with hypoxiaactivated prodrug SN30000

Summary

Use of multicellular spheroids and agent-based modelling to optimise combination therapies with hypoxiaactivated prodrug SN30000 is a doctoral thesis^[1].

Key Facts

• Use of multicellular spheroids and agent-based modelling to optimise combination therapies with hypoxiaactivated prodrug SN30000 authored Xinjian Mao^[2].
• Use of multicellular spheroids and agent-based modelling to optimise combination therapies with hypoxiaactivated prodrug SN30000's instance of is recorded as doctoral thesis^[3].
• Use of multicellular spheroids and agent-based modelling to optimise combination therapies with hypoxiaactivated prodrug SN30000's publisher is recorded as ResearchSpace@Auckland^[4].
• Use of multicellular spheroids and agent-based modelling to optimise combination therapies with hypoxiaactivated prodrug SN30000's copyright license is recorded as Creative Commons Attribution-NonCommercial-ShareAlike 3.0 New Zealand^[5].
• Use of multicellular spheroids and agent-based modelling to optimise combination therapies with hypoxiaactivated prodrug SN30000's country of origin is recorded as New Zealand^[6].
• Use of multicellular spheroids and agent-based modelling to optimise combination therapies with hypoxiaactivated prodrug SN30000's publication date is recorded as +2018-00-00T00:00:00Z^[7].
• Use of multicellular spheroids and agent-based modelling to optimise combination therapies with hypoxiaactivated prodrug SN30000's main subject is recorded as biomedical sciences^[8].
• Use of multicellular spheroids and agent-based modelling to optimise combination therapies with hypoxiaactivated prodrug SN30000's work available at URL is recorded as https://researchspace.auckland.ac.nz/handle/2292/46493^[9].
• Use of multicellular spheroids and agent-based modelling to optimise combination therapies with hypoxiaactivated prodrug SN30000's Handle ID is recorded as 2292/46493^[10].
• Use of multicellular spheroids and agent-based modelling to optimise combination therapies with hypoxiaactivated prodrug SN30000's title is recorded as Use of multicellular spheroids and agent-based modelling to optimise combination therapies with hypoxiaactivated prodrug SN30000^[11].
• Use of multicellular spheroids and agent-based modelling to optimise combination therapies with hypoxiaactivated prodrug SN30000's copyright holder is recorded as Xinjian Mao^[12].
• Use of multicellular spheroids and agent-based modelling to optimise combination therapies with hypoxiaactivated prodrug SN30000's thesis submitted to is recorded as University of Auckland^[13].
• Use of multicellular spheroids and agent-based modelling to optimise combination therapies with hypoxiaactivated prodrug SN30000's on focus list of Wikimedia project is recorded as NZThesisProject^[14].
• Use of multicellular spheroids and agent-based modelling to optimise combination therapies with hypoxiaactivated prodrug SN30000's copyright status is recorded as copyrighted^[15].
• Use of multicellular spheroids and agent-based modelling to optimise combination therapies with hypoxiaactivated prodrug SN30000's online access status is recorded as open access^[16].
• Use of multicellular spheroids and agent-based modelling to optimise combination therapies with hypoxiaactivated prodrug SN30000's thesis committee member is recorded as William Robert Wilson^[17].
• Use of multicellular spheroids and agent-based modelling to optimise combination therapies with hypoxiaactivated prodrug SN30000's thesis committee member is recorded as Kevin O Hicks^[18].

Body

Designation and Status

Use of multicellular spheroids and agent-based modelling to optimise combination therapies with hypoxiaactivated prodrug SN30000's instance of is recorded as doctoral thesis^[3].